DISCOVER
our Quality & credentials
Quality Management
at the very centre
of the Telemedicine Technologies corporate
strategy
ISO 9001:2015 certification
ISO 27001 HDS
Regulatory compliance:
21 CRF part 11 FDA
and with ICH E6-E9, ICH Q9-Q10, European Directives 2001/20/EC / Directive 2005/28/EC, Annex 11, cGMP
CDISC-ODM Certification
Information System Validation:
GAMP-5 methodology
National Qualiopi certification,
a new quality guarantee for
training providers in France
BSMA Europe (Bio Supply Management Alliance) Award received in October 2024 for the CleanWeb™-RTSM module, which streamlines supply management for randomised trials
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
October 30, 2025
February 1–3, 2025 – Amsterdam | Booth 16-17-18 We’re excited to announce our participation to EUCROF26! Visit our booth to explore CleanWeb™, our advanced eClinical suite for managing clinical trials, registries, and early access programs. Together with our CRO Alliance partners (BlueCompanion, Clinica Group, DeltaClinical, NextCRO, Phoenix CR), we offer tailored solutions to support your […]
October 30, 2025
Applied Clinical Trials Online Clinical trials have traditionally relied on paper-based consent forms to secure the participant’s approval. While this approach is still common in many studies, it presents practical challenges. Participants may struggle with dense medical jargon, documents can be misplaced, and re-consenting often adds to site workload. As decentralized and hybrid trial models […]
October 30, 2025
Biopharm International To improve patient outcomes, experience, and engagement, patient-centric drug development is essential. By focusing on patients’ needs, experiences, and preferences, drug developers can create treatments that are optimally effective and tolerated. This leads to improved adherence to treatment regimens and better overall health outcomes when compared with not taking these factors into consideration […]